Correlation Between Hepion Pharmaceuticals and Krystal Biotech
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Krystal Biotech, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Krystal Biotech.
Diversification Opportunities for Hepion Pharmaceuticals and Krystal Biotech
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hepion and Krystal is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Krystal Biotech go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Krystal Biotech
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Krystal Biotech. In addition to that, Hepion Pharmaceuticals is 2.63 times more volatile than Krystal Biotech. It trades about -0.06 of its total potential returns per unit of risk. Krystal Biotech is currently generating about 0.06 per unit of volatility. If you would invest 7,780 in Krystal Biotech on November 2, 2024 and sell it today you would earn a total of 8,331 from holding Krystal Biotech or generate 107.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Krystal Biotech
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Krystal Biotech |
Hepion Pharmaceuticals and Krystal Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Krystal Biotech
The main advantage of trading using opposite Hepion Pharmaceuticals and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |